Shanxiang Jiang Selected Research

maduramicin

12/2021	Maduramicin induces cardiotoxicity via Rac1 signaling-independent methuosis in H9c2 cells.
10/2020	Ionophore Toxin Maduramicin Produces Haff Disease-Like Rhabdomyolysis in a Mouse Model.
10/2020	Maduramicin triggers methuosis-like cell death in primary chicken myocardial cells.
1/2019	Effects of maduramicin on adult zebrafish (Danio rerio): Acute toxicity, tissue damage and oxidative stress.
1/2019	Maduramicin induces cardiac muscle cell death by the ROS-dependent PTEN/Akt-Erk1/2 signaling pathway.
8/2018	Maduramicin induces apoptosis in chicken myocardial cells via intrinsic and extrinsic pathways.
3/2018	Transcriptome profile analysis reveals cardiotoxicity of maduramicin in primary chicken myocardial cells.
1/2018	Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells.
1/2018	Maduramicin-activated protein phosphatase 2A results in extracellular signal-regulated kinase 1/2 inhibition, leading to cytotoxicity in myocardial H9c2 cells.
1/2014	Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shanxiang Jiang Research Topics

Disease

5	Cardiotoxicity 12/2021 - 01/2018
4	Coccidiosis 01/2019 - 01/2014
4	Heart Failure 01/2019 - 01/2014
3	Necrosis 03/2018 - 08/2014
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 02/2015
2	Newcastle Disease 05/2020 - 04/2014
1	COVID-19 07/2022
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Bacterial Infections (Bacterial Infection) 02/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Body Weight (Weight, Body) 10/2020
1	Weight Loss (Weight Reduction) 10/2020
1	Rhabdomyolysis 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2020
1	Infections 08/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2018
1	Parasitic Diseases (Parasitic Disease) 01/2018
1	Leukemia 02/2015
1	Rhabdomyosarcoma 01/2014

Drug/Important Bio-Agent (IBA)

10	maduramicinIBA 12/2021 - 01/2014
7	IonophoresIBA 10/2020 - 01/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2014
3	Pharmaceutical PreparationsIBA 07/2022 - 10/2020
2	halofuginoneIBA 01/2022 - 01/2021
2	MicellesIBA 01/2022 - 01/2021
2	tocophersolanIBA 01/2022 - 01/2021
2	tilmicosinIBA 02/2021 - 03/2020
1	chloroquine diphosphate FDA LinkGeneric 07/2022
1	Chloroquine (Aralen)FDA LinkGeneric 07/2022
1	AlkaloidsIBA 01/2021
1	polyethylene glycol 1000IBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Succinic Acid (Succinate)IBA 01/2021
1	Tocopherols (Tocopherol)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	QuinazolinonesIBA 01/2021
1	febrifugineIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	SolutionsIBA 05/2020
1	DNA VaccinesIBA 05/2020
1	Matrix Metalloproteinases (MMPs)IBA 02/2018
1	salinomycinIBA 02/2018
1	Delayed-Action PreparationsIBA 01/2018
1	Ivermectin (Mectizan)FDA Link 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	arprinocidIBA 08/2014
1	Polysaccharides (Glycans)IBA 04/2014
1	VaccinesIBA 04/2014

Therapy/Procedure

1	Intravenous Injections 01/2022
1	Subcutaneous Injections 01/2021
1	Therapeutics 02/2015